Tg(tetO-MAPT*K280*I277P*I308P,-luc)#Eman
Transgene Detail
|
|
| Symbol: |
Tg(tetO-MAPT*K280*I277P*I308P,-luc)#Eman |
| Name: |
transgene insertion, Eva-Maria Mandelkow |
| MGI ID: |
MGI:5554188 |
| Synonyms: |
antiaggregation, TauRD/deltaK280/I277P/I308P |
| Transgene: |
Tg(tetO-MAPT*K280*I277P*I308P,-luc)#Eman Location: unknown
|
| Alliance: |
Tg(tetO-MAPT*K280*I277P*I308P,-luc)#Eman page
|
|
| Strain of Origin: |
Not Specified
|
|
| Transgene Type: |
|
Transgenic (Inducible, Inserted expressed sequence) |
| Inducer: |
|
doxycycline/tetracycline |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: The tetracycline response element with a bidirectional CMV promoter drives inducible expression of the four-repeat domain on human MAPT (TauRD; 244-372 aa) carrying the frontotemporal dementia and parkinsonism linked to chromosome 17 Lys280 deletion (deltaK280) and two proline mutations in the hexapeptide motifs, I277P and I308P, and a luciferase gene. The Lys280 deletion accelerates aggregation while the proline mutations inhibit MAPT (Tau) aggregation.
(J:131379)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:131379 Mocanu MM, et al., The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J Neurosci. 2008 Jan 16;28(3):737-48 |
| All: |
2 reference(s) |
|